1. www.vergopharma.com
VerGo R&D Site Verna VerGo Clinical Research Site Corlim

2. www.vergopharma.com
Mission Statement
To partner with global pharmaceutical companies to meet their
R&D goals and create value with innovative solutions

3. Quality and
innovation
• QbD approach
• Successfully
developed two
NCE-1
products
• Platform
technologies
State of the art
infrastructure
• EU and TGA
approved
mfg. facility
• DCGI approved
clinical BA/BE
center
• Experienced
research
scientists
Timely
deliveries
• Proven track
record
• Integrated PM
team
• Adequate
capacities
Customer focus
• End to end
services
• Flexible
business model
• Independent
CRO
Salient Features
www.vergopharma.com

4. www.vergopharma.com
VerGo Business Verticals
Pharmaceutical
Product
Development
BA/BE Studies
Custom
Synthesis
Laboratory
End to End Services

5. www.vergopharma.com
Service Portfolio
Formulation
Development
Analytical
Development
Stability Testing
(ICH)
GMP
Manufacturing
Clinical BA/BE
Studies
Clinical Trial
Supply
Management
Custom Synthesis
Laboratory

6. www.vergopharma.com
Formulation Development Services
Formulation
Development
(By Qbd)
Preformulation
Brand Life
Cycle
Extension
Bioavailability
Enhancement
FBP
Technology
(Bosch &
Glatt)
Lyophilization
& Parenteral
Development
Process
Validation
Platform
Technologies

7. ANDA package
Product life cycle
management
NDF/[505 b(2)]
PAP/POC (proactive
patenting and proof
of concept)
EDF (early to
develop)
FTF [first to file]
• LVP
• Lyophilized
Solutions
• Ophthalmic
• Tablets –
IR/ODT/CT
• Capsules
• Liquids-
Solutions,
Suspension,
Emulsion,
Syrups
• Granules
• Tablets
• Capsules
• Tablets
• Capsules
• Pellets
• Liquids
ER/SR/
DR/MR
ODT/Taste
Masking/
Pelletisation/
Microencapsul
ation
Injectables
/Sterile
Products
IR
Formulation Development Scope
www.vergopharma.com

8. www.vergopharma.com
Analytical Development Services
Analytical
Development
Method
Development
Method
Validation
Inter-
laboratory
Method
Transfers
Stability
Assessment &
Photo-
stability
Structural
Elucidation &
Impurity
Identification
FEI 3009383919

9. www.vergopharma.com
Stability Testing Services (ICH)
Stability
Testing Study
(As per ICH
Guidelines)
Protocol
Design
Retention,
Logging and
Tracking of
samples
Stability
Testing of
API,
Finished
Product and
Containers
Semi-
permeable
Container
Testing
Expiration
Dating
Highlights:
 EU & TGA Approved
100,000L & expandable up
to 250,000L
Caters all four ICH Zones

10. www.vergopharma.com
GMP Manufacturing Services
GMP
Manufacturing
Process
Optimization
Trials
Exhibit
Batches
Manufacture
Clinical Batch
Supplies
HDPE or
Blister
Packing
OTC Sensory
Batch
Manufacture
Highlights:
 Designed for Tablets,
Capsules, MUPS, Liquid orals
 Capacities :-
Solid Orals – 5kg to 200kg
Liquid Orals – Upto 100L
Packaging (Blister/HDPE)
 R&D and GMP located in
same campus

11. www.vergopharma.com
Custom Synthesis Laboratory Services
Custom
Synthesis
Laboratory
(CSL)
Process
Development
& Scale-up
NCEs
Intermediates
Drug
Impurity
Standards
and
Metabolites
Nucleic Acid
and PET
Precursors
Nuclear
Medicine
Precursors
Highlights:
 Gram to kilo scale
 120 linear feet fume cupboard
 Hydrogen parr apparatus
 Heidolph rotary evaporators
 Fully equipped analytical support

12. www.vergopharma.com
BA/BE Services
BA/BE
Pilot & Pivotal
BA/BE Studies
Bio-analytical
Testing
Data
Management
Pathology
Center
(NABL)
Highlights:
 DCGI approved
 100 bed facility
 6 LC-MS/MS
 GLP, GCP compliant
 VIMS and OVIS software
 Fully equipped ICU

13. www.vergopharma.com
Clinical Trial Supply Management (CTSM)
CTSM
Manufacturing
Packaging
Labeling
Blinding
Randomization
Shipment or
Logistics
Highlights:
 EU & TGA approved facility
 Experienced staff
 2-8°C suite for packaging &
labeling
 End to End CTSM of solid orals
 Capability:- Biosimilars, MDIs,
sterile injectables & Solid orals

14. Platform Technologies
www.vergopharma.com

15. Platform Technologies
www.vergopharma.com
pH modulated drug
delivery system
Effervescent drug
delivery system
Low dose
formulation
technology
Sublingual
Orodispersible tablets
Multilayer single
system modified
drug delivery system

16. Business Model
 Fee for service
 Out-licensing
 Co-development
Revenue Model
 Receive up front payments and milestone based fees
 Royalties on Sales / Profit
 Supply Chain arrangement
www.vergopharma.com
Business Model
We are flexible….

17. VerGo Pharma Research
VerGo Pharma Research Laboratories Pvt. Ltd.,
Plot B-5, Verna Industrial Estate Verna,
Salcette, Goa - 403722 India.
VerGo Clinicals
Tel: +91-832- 6624858
VerGo Clinicals, Plot 24/1, D-1
Mologa de Orora Corlim, Tiswadi,
Goa - 403110 India.
Tel: +91-832- 6640400
Business Office
301/302 Opulence, 6th Road, Santacruz
(East), Mumbai Maharashtra 400055
India
Tel: +91(22) 61955955
www.vergopharma.com
Email: info@vergopharma.com
Contact Us :-

18. We look forward to your support…
Goa welcomes you!!